US prescription drug mix-ups warning

4 June 2001

The US Joint Commission of Accreditation of Healthcare Organizationshas issued a special alert about the dangers of sound-alike and look-alike prescription drug names. Despite widespread publicity, "tens of thousands of Americans still face life-threatening risks because of medication mix-ups," it says.

Medication errors resulting from confusing drug names pose a serious threat that requires immediate action, says the alert, which has gone out to nearly 19,000 hospitals, nursing homes, outpatient clinics and other health care facilities. The Commission has established a voluntary reporting system for these types of health care errors, which can be found at www.jcaho.org.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight